We’re Making History Here!
Olympian Clinical Research
MARCH 25, 2019
The FDA has voted to approve SPRAVATO TM (esketamine)! SPRAVATO TM is a nasal spray for adults with treatment-resistant depression. I know what you’re probably thinking…nasal spray?? That’s right! “SPRAVATO will offer the first new mechanism of action in 30 years to treat this debilitating disease, continuing Janssen’s 60-plus-year history and commitment to research that make a difference for people living with mental illnesses, including severe mood disorders.” [1].
Let's personalize your content